Yu Xie

1095 Jiefang Avenue
Wuhan, 430030, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

A pan-cancer analysis of the oncogenic role of KDELR2 in human cancers.

A pan-cancer analysis of the oncogenic role of KDELR2 in human cancers.

Journal: Discover oncology

Published: March 13, 2025

Pan-cancer analysis of B3GNT5 with potential implications for cancer immunotherapy and cancer stem cell stemness.

Pan-cancer analysis of B3GNT5 with potential implications for cancer immunotherapy and cancer stem cell stemness.

Journal: PloS one

Published: June 18, 2024

MiR-200b-3p elevates 5-FU sensitivity in cholangiocarcinoma cells via autophagy inhibition by targeting KLF4.

MiR-200b-3p elevates 5-FU sensitivity in cholangiocarcinoma cells via autophagy inhibition by targeting KLF4.

Journal: Non-coding RNA research

Published: February 02, 2024

Upregulation of METTL14 mediates the elevation of PERP mRNA N6 adenosine methylation promoting the growth and metastasis of pancreatic cancer.

Upregulation of METTL14 mediates the elevation of PERP mRNA N6 adenosine methylation promoting the growth and metastasis of pancreatic cancer.

Journal: Molecular cancer

Published: February 29, 2020

Three-lncRNA signature is a potential prognostic biomarker for pancreatic adenocarcinoma.

Three-lncRNA signature is a potential prognostic biomarker for pancreatic adenocarcinoma.

Journal: Oncotarget

Published: August 23, 2017

Regulatory B cells induced by pancreatic cancer cell-derived interleukin-18 promote immune tolerance via the PD-1/PD-L1 pathway.

Regulatory B cells induced by pancreatic cancer cell-derived interleukin-18 promote immune tolerance via the PD-1/PD-L1 pathway.

Journal: Oncotarget

Published: May 19, 2017

Circulating myeloid-derived suppressor cells in patients with pancreatic cancer.

Circulating myeloid-derived suppressor cells in patients with pancreatic cancer.

Journal: Hepatobiliary & pancreatic diseases international : HBPD INT

Published: January 29, 2016

Blocking NF-κB Is Essential for the Immunotherapeutic Effect of Recombinant IL18 in Pancreatic Cancer.

Blocking NF-κB Is Essential for the Immunotherapeutic Effect of Recombinant IL18 in Pancreatic Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: May 18, 2015

Par3 regulates invasion of pancreatic cancer cells via interaction with Tiam1.

Par3 regulates invasion of pancreatic cancer cells via interaction with Tiam1.

Journal: Clinical and experimental medicine

Published: February 28, 2015

Showing 1-9 of 9

Last Updated: 09/26/2026